Neurovascular Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices), By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others), By End User (Hospitals, Specialty Clinics, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 7.92 Billion
CAGR (2026-2031)	6.37%
Fastest Growing Segment	Cerebral Aneurysm
Largest Market	North America
Market Size (2031)	USD 11.47 Billion

Market Overview

The Global Neurovascular Devices Market is projected to grow from USD 7.92 Billion in 2025 to USD 11.47 Billion by 2031 at a 6.37% CAGR. Neurovascular devices comprise specialized medical instruments designed to diagnose, treat, and manage conditions affecting the blood vessels of the brain and spine, including cerebral aneurysms, ischemic strokes, and arteriovenous malformations. These devices encompass a range of technologies such as guidewires, catheters, stents, and embolization coils, facilitating minimally invasive interventional procedures. The market's expansion is significantly driven by the escalating global incidence of neurovascular diseases, a growing geriatric population highly susceptible to these conditions, and a strong preference for less invasive surgical techniques offering improved patient outcomes.

A key driver includes the continuous development of advanced device designs and enhanced imaging compatibility, which bolsters procedural efficiency and safety. According to the World Stroke Organization, in its Global Stroke Fact Sheet 2025, there are almost 12 million new strokes each year globally. Despite these supportive factors, a significant impediment to market growth is the high procedural costs associated with neurovascular interventions and devices, which can limit access to advanced care, particularly in developing regions.

Key Market Drivers

Rising incidence of neurovascular disorders
Rising incidence of neurovascular disorders directly drives demand for devices used in diagnosing and treating conditions affecting brain blood vessels. These conditions, such as strokes and aneurysms, necessitate specialized interventional procedures. The prevalence and severity of these health issues underscore the continuous need for advanced therapeutic and diagnostic tools. According to the American Heart Association, in its 2025 Heart Disease and Stroke Statistics report, cardiovascular disease, which includes stroke, accounted for approximately 19.41 million global deaths in 2021. This significant health burden fuels sustained investment and adoption of neurovascular technologies aimed at improving patient outcomes and reducing mortality rates. Enhanced diagnostic capabilities also contribute to an expanding patient pool.

Expanding geriatric population
The expanding global geriatric population constitutes another critical driving force for the neurovascular devices market. Elderly individuals are more susceptible to age-related neurovascular disorders like ischemic stroke and intracranial aneurysms due to physiological changes. This demographic shift significantly increases the potential patient base for neurovascular interventions. According to the World Health Organization, in October 2025, the global population of people aged 60 and above is projected to increase from 1.1 billion in 2023 to 1.4 billion by 2030. This growth in the elderly cohort translates into sustained demand for neurovascular devices and procedures. Moreover, the market exhibits robust activity, with Penumbra, Inc. reporting, in May 2026, first-quarter 2026 revenue of $374.8 million, a 15.6% increase compared to the first quarter of 2025. This performance demonstrates the sector's continued expansion.

Download Free Sample Report

Key Market Challenges

High procedural costs associated with neurovascular interventions and specialized devices present a significant market impediment. These substantial expenses, encompassing device procurement, hospital stays, and the specialized expertise required for complex procedures, impose a considerable financial burden on healthcare systems. This elevated cost particularly limits patient access to advanced neurovascular care, especially in developing regions where healthcare budgets are often constrained. Consequently, the adoption rate of innovative neurovascular devices can be slowed as providers and payers prioritize more cost-effective, albeit potentially less advanced, treatment options.

Further exacerbating this challenge, adjustments to reimbursement policies can directly impact the provision of care. According to the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS), in September 2025, the overall impact of proposed 2026 Medicare Physician Fee Schedule provisions for neurosurgery indicated a 5 percent decrease in reimbursement. This unsustainable reduction, given rising practice costs, is projected to inevitably diminish access to neurosurgical care for Medicare beneficiaries, thereby impeding market growth by reducing the volume of procedures performed.

Key Market Trends

The integration of artificial intelligence and robotics is significantly transforming neurovascular interventions by enhancing precision, efficiency, and safety in diagnostic and procedural applications. AI algorithms are increasingly utilized for advanced image analysis, disease detection, and procedural planning, while robotic systems provide augmented dexterity and stability during complex surgeries. This technological convergence aims to optimize procedural outcomes, reduce radiation exposure, and minimize complications for patients. For example, Siemens Healthineers, a company actively developing endovascular robotics for neurovascular procedures, possesses an extensive collection of AI patents in medical imaging, and its supercomputer Sherlock has a computing capacity of 100 petaflops, highlighting significant investment in computational power for healthcare advancements.

Strategic collaborations and partnerships are crucial for accelerating innovation and expanding market access within the global neurovascular devices sector. Companies are increasingly forming alliances, including mergers and acquisitions, for research and development, co-marketing, and distribution to leverage complementary expertise and access new geographic regions. Such initiatives facilitate the rapid development and commercialization of next-generation devices, addressing the substantial capital and regulatory challenges inherent in medical device innovation. Illustrating this trend, Boston Scientific agreed to acquire Penumbra in a transaction valued at approximately $14.5 billion, announced in January 2026, aimed at expanding its offerings in high-growth segments of vascular care.

Segmental Insights

The Cerebral Aneurysm segment is recognized as a fastest-growing application within the global neurovascular devices market. This rapid expansion is primarily driven by the increasing worldwide prevalence of cerebral aneurysms, often linked to rising hypertension and sedentary lifestyles. Furthermore, continuous technological advancements in endovascular treatment options, such as sophisticated embolization coils and flow diverters, enhance procedural efficacy and patient outcomes. The growing adoption of minimally invasive techniques, supported by efforts from medical institutions to improve early diagnosis and intervention, significantly contributes to this segment's accelerated growth. Regulatory bodies like the U.S. Food and Drug Administration also influence the development and market introduction of these specialized devices.

Regional Insights

North America holds a dominant position in the global neurovascular devices market due to several key factors. The region benefits from a well-established healthcare infrastructure, high healthcare expenditure, and significant awareness regarding neurovascular diseases and their treatment options. Strong research and development activities, coupled with the presence of major industry players and supportive regulatory frameworks from bodies such as the U.S. Food and Drug Administration (FDA), foster innovation and product adoption. Additionally, a higher prevalence of target diseases and proactive reimbursement policies further contribute to North America's market leadership.

Recent Developments

• In May 2026, Terumo Neuro announced that its WovenEndoBridge™ 17 Aneurysm Embolization System received approval in Japan. This pioneering neurovascular device, supported by more than 15 years of clinical data, is designed for treating ruptured aneurysms. The system aims to transform the treatment approach for patients with complex aneurysms by offering a new solution within the global neurovascular devices market. This regulatory milestone enhances Terumo Neuro’s comprehensive portfolio of devices, which are developed to improve patient outcomes in hemorrhagic stroke.
• In March 2026, Medtronic entered a definitive agreement to acquire Scientia Vascular for $550 million, a strategic move intended to strengthen its neurovascular portfolio. Scientia Vascular's innovative guidewires and catheters are designed to improve navigability through complex cerebral anatomy, aiming to simplify neurovascular procedures. This acquisition will enable Medtronic to offer an expanded suite of products, enhancing its capabilities in treating both hemorrhagic and acute ischemic stroke. The integration of Scientia’s access products with Medtronic’s existing therapies is expected to drive significant advancements in global neurovascular care.
• In March 2026, Johnson & Johnson MedTech officially launched three new neurovascular devices: the Cereglide 42 and Cereglide 57 aspiration catheters, and the Innerglide 7 deliver aid. These devices expand the company’s aspiration-first stroke portfolio and are designed to help clinicians reach and remove distal clots associated with stroke efficiently. The catheters incorporate proprietary technology that provides both support and flexibility, along with radiopaque tip markers for improved visibility and a hydrophilic coating to minimize potential anatomical damage during treatment, thereby addressing challenges in global stroke intervention.
• In September 2025, Stryker and Siemens Healthineers announced a strategic partnership to develop a robotic system for a comprehensive range of elective and emergency neurovascular procedures, including treatments for strokes and aneurysms. This collaboration combines Siemens Healthineers' expertise in robotics and imaging with Stryker's experience in neurovascular technologies. The objective is to enhance procedural precision, improve physician performance, and enable faster treatment, thereby improving patient outcomes in complex hemorrhagic cases and time-sensitive ischemic strokes within the global neurovascular devices market.

Key Market Players

• Medtronic plc
• Stryker Corporation
• Terumo Corporation
• Penumbra Inc.
• Johnson & Johnson Services Inc.
• Integra LifeSciences Corporation
• Acandis GmbH
• Spiegelberg GmbH & Co. KG
• MicroPort Scientific Corporation
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO. LTD.

By Device	By Therapeutic Application	By End User	By Region
Cerebral Embolization and Aneurysm Coiling Devices Cerebral Angioplasty and Stenting Systems Neurothrombectomy Devices Support Devices Trans Radial Access Devices	Stroke Cerebral Artery Cerebral Aneurysm Others	Hospitals Specialty Clinics Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Neurovascular Devices Market , By Device:

• Cerebral Embolization and Aneurysm Coiling Devices
• Cerebral Angioplasty and Stenting Systems
• Neurothrombectomy Devices
• Support Devices
• Trans Radial Access Devices

• Neurovascular Devices Market , By Therapeutic Application:

• Stroke
• Cerebral Artery
• Cerebral Aneurysm
• Others

• Neurovascular Devices Market , By End User:

• Hospitals
• Specialty Clinics
• Others

• Neurovascular Devices Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE